These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28640844)

  • 1. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.
    Agemi Y; Shimokawa T; Sasaki J; Miyazaki K; Misumi Y; Sato A; Aida S; Ishii M; Nakamura Y; Naoki K; Okamoto H
    PLoS One; 2019; 14(1):e0210499. PubMed ID: 30653558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First validation of the G-8 geriatric screening tool in older patients with glioblastoma.
    Deluche E; Leobon S; Lamarche F; Tubiana-Mathieu N
    J Geriatr Oncol; 2019 Jan; 10(1):159-163. PubMed ID: 30037767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of two geriatric screening tools in older patients with cancer.
    Kenis C; Decoster L; Van Puyvelde K; De Grève J; Conings G; Milisen K; Flamaing J; Lobelle JP; Wildiers H
    J Clin Oncol; 2014 Jan; 32(1):19-26. PubMed ID: 24276775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the G8 screening tool in elderly patients with oral squamous cell carcinoma.
    Yamada SI; Hasegawa T; Okuyama K; Yamakawa N; Okura M; Hashidume M; Yanamoto S; Akashi M; Kirita T; Umeda M; Kurita H
    Clin Oral Investig; 2020 Jun; 24(6):1953-1961. PubMed ID: 31410674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
    Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
    J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
    Schulkes KJG; Souwer ETD; van Elden LJR; Codrington H; van der Sar-van der Brugge S; Lammers JJ; Portielje JEA; van den Bos F; Hamaker ME
    Clin Lung Cancer; 2017 Nov; 18(6):660-666.e1. PubMed ID: 28320638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures of functional status in older patients treated with palbociclib for advanced breast cancer.
    Karuturi MS; Cappelleri JC; Blum JL; Patel K; Telivala B; McCune S; Cuevas JD; Lakhanpal S; Montelongo MZ; Wang Y; Tripathy D; Rocque GB
    J Geriatr Oncol; 2024 Jan; 15(1):101670. PubMed ID: 38061288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
    Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
    J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer.
    Fagard K; Casaer J; Wolthuis A; Flamaing J; Milisen K; Lobelle JP; Wildiers H; Kenis C
    J Geriatr Oncol; 2017 Sep; 8(5):320-327. PubMed ID: 28781062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three Years Survival of Elderly Cancer Patients in Indonesia: Do We Need a Different Approach?
    Sutandyo N; Kurniawati SA; Siregar NN; Sari NK
    Acta Med Indones; 2020 Jan; 52(1):39-46. PubMed ID: 32291370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
    Arslan D; Tural D; Koca T; Tastekin D; Kaymak Cerkesli A; Basaran H; Gunduz S; Murat Tatli A; Sezgin Goksu S; Uysal M; Kargi A; Kargi B; Koral L; Ibrahim Bassorgun C; Unal D; Mutlu H; Senol Coskun H; Ozdogan M; Bozcuk H
    J BUON; 2015; 20(2):573-9. PubMed ID: 26011352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
    Käsmann L; Taugner J; Eze C; Roengvoraphoj O; Dantes M; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
    Anticancer Res; 2019 Sep; 39(9):5077-5081. PubMed ID: 31519618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
    Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
    Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
    Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
    J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy.
    Song T; Wan Q; Yu W; Li J; Lu S; Xie C; Wang H; Fang M
    Oncotarget; 2017 Nov; 8(58):98974-98984. PubMed ID: 29228742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
    Choi YW; Ahn MS; Jeong GS; Lee HW; Jeong SH; Kang SY; Park JS; Choi JH; Lee SY
    Lung Cancer; 2015 Feb; 87(2):155-61. PubMed ID: 25488862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
    Vivaldi C; Caparello C; Musettini G; Pasquini G; Catanese S; Fornaro L; Lencioni M; Falcone A; Vasile E
    Int J Cancer; 2016 Aug; 139(4):938-45. PubMed ID: 27038273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.